US3919205A
(en)
|
1972-07-17 |
1975-11-11 |
Squibb & Sons Inc |
Dithiocarbonylthioacetyl cephalosporin derivatives
|
US5166331A
(en)
|
1983-10-10 |
1992-11-24 |
Fidia, S.P.A. |
Hyaluronics acid fractions, methods for the preparation thereof, and pharmaceutical compositions containing same
|
FR2654725B1
(fr)
|
1989-11-23 |
1992-02-14 |
Rhone Poulenc Sante |
Nouveaux derives de l'isoindolone, leur preparation et les compositions pharmaceutiques qui les contiennent.
|
US5420297A
(en)
|
1990-10-24 |
1995-05-30 |
Fujisawa Pharmaceutical Co., Ltd. |
Peptides having substance P antagonistic activity
|
FR2676055B1
(fr)
|
1991-05-03 |
1993-09-03 |
Sanofi Elf |
Composes polycycliques amines et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant.
|
DE69208877T2
(de)
|
1991-05-31 |
1996-07-25 |
Pfizer |
Chinuclidinderivate
|
GB9113219D0
(en)
|
1991-06-19 |
1991-08-07 |
Fujisawa Pharmaceutical Co |
Peptide compound,processes for preparation thereof and pharmaceutical composition comprising the same
|
EP0593557B1
(en)
|
1991-07-05 |
1996-01-31 |
MERCK SHARP & DOHME LTD. |
Aromatic compounds, pharmaceutical compositions containing them and their use in therapy
|
US5552534A
(en)
|
1991-08-22 |
1996-09-03 |
The Trustees Of The University Of Pennsylvania |
Non-Peptide peptidomimetics
|
PT533280E
(pt)
|
1991-09-20 |
2001-01-31 |
Glaxo Group Ltd |
Novas utilizacoes medicas para antagonistas de taquiquinina
|
GB9200535D0
(en)
|
1992-01-10 |
1992-02-26 |
Fujisawa Pharmaceutical Co |
New compound
|
WO1993017032A1
(en)
|
1992-02-24 |
1993-09-02 |
The Trustees Of The University Of Pennsylvania |
Techniques and intermediates for preparing non-peptide peptidomimetics
|
FR2689889B1
(fr)
|
1992-04-10 |
1994-06-10 |
Rhone Poulenc Rorer Sa |
Nouveaux derives de perhydroisoindole, et leur preparation.
|
TW241258B
(nl)
|
1992-04-15 |
1995-02-21 |
Takeda Pharm Industry Co Ltd |
|
US6048859A
(en)
|
1992-06-29 |
2000-04-11 |
Merck & Co., Inc. |
Morpholine and thiomorpholine tachykinin receptor antagonists
|
US5719147A
(en)
|
1992-06-29 |
1998-02-17 |
Merck & Co., Inc. |
Morpholine and thiomorpholine tachykinin receptor antagonists
|
IL111002A
(en)
|
1993-09-22 |
1998-09-24 |
Glaxo Group Ltd |
History of piperidine, their preparation and the pharmaceutical preparations containing them
|
US6403577B1
(en)
|
1993-11-17 |
2002-06-11 |
Eli Lilly And Company |
Hexamethyleneiminyl tachykinin receptor antagonists
|
IL111730A
(en)
|
1993-11-29 |
1998-12-06 |
Fujisawa Pharmaceutical Co |
Piperazine derivatives, processes for their preparation and pharmaceutical preparations containing them
|
IL112778A0
(en)
|
1994-03-04 |
1995-05-26 |
Merck & Co Inc |
Substituted heterocycles, their preparation and pharmaceutical compositions containing them
|
FR2718136B1
(fr)
|
1994-03-29 |
1996-06-21 |
Sanofi Sa |
Composés aromatiques aminés, procédé pour leur obtention et compositions pharmaceutiques les contenant.
|
HUT77318A
(hu)
|
1994-09-30 |
1998-03-30 |
Novartis Ag. |
1-Acil-4-/(alifás amino)-piperidin/-származékok, e vegyületeket tartalmazó gyógyszerkészítmények, eljárás előállításukra és alkalmazásuk
|
HU226562B1
(en)
|
1995-02-22 |
2009-04-28 |
Novartis Ag |
1-aryl-2-acylamino-ethane compounds as neurokinin, especially neurokinin-1 antagonists, and medicaments containing the said compounds.
|
GB9505692D0
(en)
|
1995-03-21 |
1995-05-10 |
Glaxo Group Ltd |
Chemical compounds
|
US5886011A
(en)
|
1995-03-27 |
1999-03-23 |
Hisamitsu Pharmaceutical Co., Inc. |
Piperidine derivatives as substance P antagonists
|
DE19519245C2
(de)
|
1995-04-14 |
2003-04-30 |
Boehringer Ingelheim Kg |
Neue Arylglycinamidderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
|
GB9510600D0
(en)
|
1995-05-25 |
1995-07-19 |
Fujisawa Pharmaceutical Co |
Piperazine derivatives
|
TW382017B
(en)
|
1995-12-27 |
2000-02-11 |
Janssen Pharmaceutica Nv |
1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives
|
DE19608665A1
(de)
|
1996-03-06 |
1997-09-11 |
Boehringer Ingelheim Kg |
Neue Arylglycinamidderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
|
US5929094A
(en)
|
1996-10-25 |
1999-07-27 |
Merck & Co., Inc. |
Heteroaryl spiroethercycloalkyl tachykinin receptor antagonists
|
WO1998017660A1
(en)
|
1996-10-25 |
1998-04-30 |
Merck & Co., Inc. |
Phenyl spiroethercycloalkyl tachykinin receptor antagonists
|
GB9625843D0
(en)
|
1996-12-12 |
1997-01-29 |
Merck & Co Inc |
Phenyl spiroethercycloalkyl tachykinn receptor antagonists
|
GB9700597D0
(en)
|
1997-01-14 |
1997-03-05 |
Sandoz Pharma Uk |
Organic compounds
|
JPH10259184A
(ja)
|
1997-03-18 |
1998-09-29 |
Takeda Chem Ind Ltd |
三環性複素環化合物の製造法
|
ZA985765B
(en)
|
1997-07-02 |
1999-08-04 |
Merck & Co Inc |
Polymorphic form of a tachykinin receptor antagonist.
|
US6339094B1
(en)
|
1997-08-06 |
2002-01-15 |
Eli Lilly And Company |
2-acylaminopropanamines as tachykinin receptor antagonists
|
TW426667B
(en)
|
1997-11-19 |
2001-03-21 |
Pfizer |
Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance P antagonists
|
GB9905010D0
(en)
|
1999-03-04 |
1999-04-28 |
Merck Sharp & Dohme |
Therapeutic agents
|
US6291465B1
(en)
|
1999-03-09 |
2001-09-18 |
Hoffmann-La Roche Inc. |
Biphenyl derivatives
|
CO5150225A1
(es)
|
1999-03-19 |
2002-04-29 |
Merck Sharp & Dohme |
Derivados del tetrahidropirano y su uso como agentes terapeuticos
|
GB9907571D0
(en)
|
1999-04-06 |
1999-05-26 |
Zeneca Ltd |
Compounds
|
ATE290034T1
(de)
|
1999-05-10 |
2005-03-15 |
Diolen Ind Fibers Gmbh |
Fadenbildende polyester und copolyester und verfahren zu deren herstellung
|
JP3229294B2
(ja)
|
1999-06-04 |
2001-11-19 |
キヤノン販売株式会社 |
被成膜面の改質方法及び半導体装置の製造方法
|
GB9923748D0
(en)
|
1999-10-07 |
1999-12-08 |
Glaxo Group Ltd |
Chemical compounds
|
WO2001025233A1
(fr)
|
1999-10-07 |
2001-04-12 |
Hisamitsu Pharmaceutical Co., Inc. |
Derives de piperidine
|
EP1276729B1
(en)
|
2000-04-06 |
2008-07-09 |
AstraZeneca AB |
New neurokinin antagonists for use as medicaments
|
WO2001077069A1
(en)
|
2000-04-06 |
2001-10-18 |
Astrazeneca Ab |
Naphthamide neurokinin antagonists for use as medicaments
|
GB0012240D0
(en)
|
2000-05-19 |
2000-07-12 |
Merck Sharp & Dohme |
Therapeutic agents
|
CN1327997A
(zh)
|
2000-06-12 |
2001-12-26 |
上海博德基因开发有限公司 |
一种新的多肽——Ras GTP酶激活蛋白9.57和编码这种多肽的多核苷酸
|
DE10036818A1
(de)
|
2000-07-28 |
2002-02-07 |
Solvay Pharm Gmbh |
Neue N-Triazolylmethyl-Piperazinderivate als Neurokininrezeptor-Antagonisten
|
PE20020444A1
(es)
|
2000-09-22 |
2002-06-14 |
Merck & Co Inc |
Antagonistas de receptores de taquiquinina zwitterionica
|
SE0003476D0
(sv)
|
2000-09-28 |
2000-09-28 |
Astrazeneca Ab |
Compounds
|
GB0025354D0
(en)
|
2000-10-17 |
2000-11-29 |
Glaxo Group Ltd |
Chemical compounds
|
US6642226B2
(en)
|
2001-02-06 |
2003-11-04 |
Hoffman-La Roche Inc. |
Substituted phenyl-piperidine methanone compounds
|
GB0108595D0
(en)
|
2001-04-05 |
2001-05-23 |
Glaxo Group Ltd |
Chemical compounds
|
GB0114867D0
(en)
|
2001-06-18 |
2001-08-08 |
Merck Sharp & Dohme |
Therapeutic agents
|
GB0119797D0
(en)
|
2001-08-14 |
2001-10-03 |
Glaxo Group Ltd |
Chemical compounds
|
EP1295599A1
(en)
|
2001-09-21 |
2003-03-26 |
Boehringer Ingelheim International GmbH |
Method for the treatment of prevention of atopic dermatitis
|
PE20030762A1
(es)
|
2001-12-18 |
2003-09-05 |
Schering Corp |
Compuestos heterociclicos como antagonistas nk1
|
ATE427310T1
(de)
|
2002-01-18 |
2009-04-15 |
Kyorin Seiyaku Kk |
Kondensierte bicyclische pyrimidinderivate
|
US7482365B2
(en)
|
2002-02-08 |
2009-01-27 |
Glaxo Group Limited |
Piperidylcarboxamide derivatives and their use in the treatment of tachykinin-mediated diseases
|
GB0203022D0
(en)
|
2002-02-08 |
2002-03-27 |
Glaxo Group Ltd |
Chemical compounds
|
GB0203020D0
(en)
|
2002-02-08 |
2002-03-27 |
Glaxo Group Ltd |
Chemical compounds
|
JP2004002334A
(ja)
|
2002-03-25 |
2004-01-08 |
Tanabe Seiyaku Co Ltd |
医薬組成物
|
NZ535886A
(en)
|
2002-04-26 |
2007-07-27 |
Lilly Co Eli |
Triazole derivatives as tachykinin receptor antagonists
|
DE60330794D1
(de)
|
2002-07-03 |
2010-02-11 |
Glaxo Group Ltd |
Substituierte 4-phenylpiperidinamide als tachykininantagonisten und serotoninwiederaufnahmehemmer
|
GB0215392D0
(en)
|
2002-07-03 |
2002-08-14 |
Glaxo Group Ltd |
Chemical compounds
|
GB0217068D0
(en)
|
2002-07-23 |
2002-08-28 |
Merck Sharp & Dohme |
Therapeutic agents
|
GB0220953D0
(en)
|
2002-09-10 |
2002-10-23 |
Novartis Ag |
Organic compounds
|
GB0310724D0
(en)
|
2003-05-09 |
2003-06-11 |
Glaxo Group Ltd |
Chemical compounds
|
WO2005019225A1
(ja)
|
2003-08-21 |
2005-03-03 |
Kyorin Pharmaceutical Co., Ltd. |
Nk1受容体拮抗作用を有する化合物の製造方法及びその製造中間体
|
AR047439A1
(es)
|
2004-01-27 |
2006-01-18 |
Merck & Co Inc |
Antagonistas del receptor hidroisoindolina taquiquinina
|
US8108430B2
(en)
|
2004-04-30 |
2012-01-31 |
Microsoft Corporation |
Carousel control for metadata navigation and assignment
|
GB0412865D0
(en)
|
2004-06-09 |
2004-07-14 |
Glaxo Group Ltd |
Chemical compounds
|
EP1819677A4
(en)
|
2004-12-03 |
2009-03-11 |
Merck & Co Inc |
8-phenyl-5,6,7,8-hydroquinolin tachykinin-ANTAGONISTS
|
JP2008521905A
(ja)
|
2004-12-03 |
2008-06-26 |
メルク エンド カムパニー インコーポレーテッド |
キノリンタキキニン受容体拮抗薬
|
US7354922B2
(en)
|
2004-12-14 |
2008-04-08 |
Schering Corporation |
Bridged ring NK1 antagonists
|
CA2590039A1
(en)
|
2004-12-14 |
2006-06-22 |
Merck & Co., Inc. |
Octahydropyrano[3,4-c]pyrrole tachykinin receptor antagonists
|
CA2603030C
(en)
|
2005-03-31 |
2013-11-19 |
Nippon Zoki Pharmaceutical Co., Ltd. |
Benzyloxypropylamine derivative
|
EP1965794A4
(en)
|
2005-12-22 |
2009-10-21 |
Merck & Co Inc |
OCTAHYDROPYRANO [3,4-c] pyrrole tachykinin receptor Antagonist
|
WO2007074491A1
(en)
|
2005-12-28 |
2007-07-05 |
Universita Degli Studi Di Siena |
HETEROTRICYCLIC AMIDE DERIVATIVES AS NEUROKININ-l (NKl) RECEPTOR LIGANDS
|
JP2007277231A
(ja)
|
2006-03-16 |
2007-10-25 |
Tanabe Seiyaku Co Ltd |
医薬組成物
|
WO2007136570A2
(en)
|
2006-05-15 |
2007-11-29 |
Merck & Co., Inc. |
5,6-fused pyrrolidine compounds useful as tachykinin receptor antagonists
|
JP2010507617A
(ja)
|
2006-10-26 |
2010-03-11 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
呼吸器系及び消化器系障害の治療用の新規な医薬組成物
|
JP2008239618A
(ja)
|
2007-02-28 |
2008-10-09 |
Mitsubishi Tanabe Pharma Corp |
医薬組成物
|
CA2690737A1
(en)
|
2007-06-22 |
2008-12-31 |
Merck Sharp & Dohme Corp. |
6.5-pyrrolopiperidine tachykinin receptor antagonists
|
CA2715781C
(en)
*
|
2008-02-26 |
2016-06-28 |
Sandoz Ag |
Preparation of morpholine derivatives
|
US20100098772A1
(en)
|
2008-10-21 |
2010-04-22 |
Allergan, Inc. |
Drug delivery systems and methods for treating neovascularization
|
ES2623503T3
(es)
*
|
2009-11-18 |
2017-07-11 |
Helsinn Healthcare Sa |
Composiciones para tratar náuseas y vómitos mediados centralmente
|
US9197705B2
(en)
|
2013-04-12 |
2015-11-24 |
Samsung Electronics Co., Ltd. |
Method and apparatus for supporting driving using wireless communication network and system thereof
|
US11915196B2
(en)
|
2019-05-23 |
2024-02-27 |
Capital One Services, Llc |
Self-service lender portal
|